DEXAMETHASONE, ELRANATAMAB, CC-92480, CC-92480, CC-92480, CC-92480, CC-92480, CC-92480
CA057-1040
Phase 2 small_molecule active
Quick answer
DEXAMETHASONE, ELRANATAMAB, CC-92480, CC-92480, CC-92480, CC-92480, CC-92480, CC-92480 for Relapsed or Refractory Multiple Myeloma (RRMM) is a Phase 2 program (small_molecule) at Celgene Europe Limited with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Celgene Europe Limited
- Indication
- Relapsed or Refractory Multiple Myeloma (RRMM)
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active